Clinical Trial Update: Study Investigating the Long-Term Safety and Tolerability of Repeated Doses of Degarelix in Prostate Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 study evaluating long-term safety and tolerability of repeated degarelix doses in prostate cancer; the trial was terminated but results were posted in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Firmagon (Degarelix)

Snippet

Sponsor: Ferring Pharmaceuticals | Conditions: Prostate Cancer | Phase 2 | Status: TERMINATED | Results posted: 2009-06-11